Target intelligence / Profile preview

Influenza viral RNA-dependent RNA polymerase (RdRp)

Target
RdRp
Molecular classification
Enzyme, RNA-dependent RNA polymerase, Heterotrimeric protein complex
01

Overview

The influenza viral RNA-dependent RNA polymerase (RdRp) is a heterotrimeric enzyme complex essential for the replication and transcription of the influenza virus genome. It is composed of three distinct subunits: polymerase acidic (PA), polymerase basic 1 (PB1), and polymerase basic 2 (PB2), which together form a functional unit within the viral ribonucleoprotein (vRNP) complex. The RdRp is responsible for synthesizing both messenger RNA (mRNA) for viral protein production and genomic RNA (vRNA) for the assembly of new virions. A hallmark of its function is the "cap-snatching" mechanism, where the PB2 subunit binds host pre-mRNAs and the PA subunit cleaves them to provide primers for viral transcription. Due to its indispensable role in the viral life cycle and high conservation across different influenza strains, the RdRp is a major target for antiviral therapy. Drugs such as baloxavir marboxil and favipiravir specifically inhibit different subunits of this complex to halt viral proliferation.

Other names
Influenza virus RNA polymerase complexFluPolPA-PB1-PB2 complexInfluenza RNA replicaseInfluenza transcriptase
02

Biological functions

Viral RNA replicationViral RNA transcriptionCap-snatchingEndonuclease activityRNA-dependent RNA polymerase activityPolyadenylation
03

Disease associations

InfectionInfluenza AInfluenza BInfluenza CInfluenza DPneumonia
04

Safety considerations

Rapid emergence of drug resistance (e.g., PA I38T mutation)Teratogenicity (associated with Favipiravir)Species-specific efficacy (e.g., Pimodivir is only active against Influenza A)Gastrointestinal side effects
05

Interacting drugs

Baloxavir marboxil

4 more in the full profile.

06

Biomarkers

Viral RNA loadPA I38T/F/M mutation (Baloxavir resistance)PB2 amino acid substitutions (Pimodivir resistance)Viral titer in respiratory secretions

Beyond the preview

Go deeper on Influenza viral RNA-dependent RNA polymerase (RdRp).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza viral RNA-dependent RNA polymerase (RdRp).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call